webinar register page

Webinar banner
Patient Guide to Clinical Trials and Drug Development: Phases and Terminology Explained!
Speaker: Danielle Quarles, Director of Clinical Operations, Sana Biotechnology

Have you read announcements for clinical trials but don’t quite understand what they mean? Do you want to feel comfortable advocating for yourself when discussing clinical trial options with your doctor? Join us to learn about drug development including how clinical trials are planned, the phases they go through, and the role that patients play in clinical trial conduct. We will cover questions to ask your doctor, things to consider when evaluating whether to participate in a trial, and how your participation could move alopecia areata treatments closer to FDA approval. Speaker Danielle Quarles will share her expertise in this area. This presentation will focus on clinical trials for adults.

This webinar is part of NAAF’s You Are Not Alone: Education and Empowerment Webinar Series. NAAF gratefully acknowledges support for this webinar series from Eli Lilly and Company.

NAAF is collecting data on its reach in the alopecia areata community. Please help us serve you better by providing some information about yourself in the registration questions below. Thank you.

Feb 15, 2023 06:00 PM in Central Time (US and Canada)

* Required information
Loading

Speakers

Danielle Quarles
Director of Clinical Operations, Sana Biotechnology
Danielle Quarles has over 20 years of experience in clinical research and drug development. She is currently Senior Director of Clinical Operations at Sana Biotechnology, leading cell and gene therapy oncology clinical trials. Danielle has two children with alopecia areata and has been active with NAAF and in the AA community for the past 11 years. Her oldest son, Connolly (now age 14), was diagnosed with AA at age 3, and her youngest son, Damon (now age 8), was diagnosed at age 18 months. Danielle’s drug development background, specifically knowledge about the high cost of developing new therapies, has led her to fundraise over $100,000 for NAAF via fun, community-based events. Danielle is a sought-after public speaker, and is known for her accessible, approachable style when explaining complex drug development topics.